Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Haddad

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 6, 2018
A Primary Care Ultrasound Fellowship: Training for Clinical Practice and Future EducatorsKeith R Barron, Michael S Wagner, Patrick S Hunt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 20, 2022
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity CancersHina Shah, Yating Wang, Su-Chun Cheng, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2007
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomiaMark S Chambers, Christopher Uwe Jones, Merrill A Biel, et al.
Epigenomics|June 13, 2024
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitorsMin Kyung Lee, Ze Zhang, Kartik Sehgal, et al.
The Oncologist|February 16, 2018
Cabozantinib in Patients with Advanced Merkel Cell CarcinomaGuilherme Rabinowits, Cecilia Lezcano, Paul J Catalano, et al.
Frontiers in Oncology|March 14, 2019
Everolimus in Anaplastic Thyroid Cancer: A Case SeriesEthan J Harris, Glenn J Hanna, Nicole Chau, et al.
Journal for Immunotherapy of Cancer|February 20, 2025
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumorsJason J Luke, David J Pinato, Dejan Juric, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancerMd Saiful Islam Saif, Kartik Sehgal, Ze Zhang, et al.
The Oncologist|February 18, 2017
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary GuidelineAhmed Sultan, Glenn J Hanna, Danielle N Margalit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2025
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor OutcomesPatricia McCoon, Ying Wang, Zhongwu Lai, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 6, 2018
A Primary Care Ultrasound Fellowship: Training for Clinical Practice and Future EducatorsKeith R Barron, Michael S Wagner, Patrick S Hunt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 20, 2022
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity CancersHina Shah, Yating Wang, Su-Chun Cheng, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2007
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomiaMark S Chambers, Christopher Uwe Jones, Merrill A Biel, et al.
Epigenomics|June 13, 2024
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitorsMin Kyung Lee, Ze Zhang, Kartik Sehgal, et al.
The Oncologist|February 16, 2018
Cabozantinib in Patients with Advanced Merkel Cell CarcinomaGuilherme Rabinowits, Cecilia Lezcano, Paul J Catalano, et al.
Frontiers in Oncology|March 14, 2019
Everolimus in Anaplastic Thyroid Cancer: A Case SeriesEthan J Harris, Glenn J Hanna, Nicole Chau, et al.
Journal for Immunotherapy of Cancer|February 20, 2025
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumorsJason J Luke, David J Pinato, Dejan Juric, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2025
A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancerMd Saiful Islam Saif, Kartik Sehgal, Ze Zhang, et al.
The Oncologist|February 18, 2017
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary GuidelineAhmed Sultan, Glenn J Hanna, Danielle N Margalit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2025
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor OutcomesPatricia McCoon, Ying Wang, Zhongwu Lai, et al.
Pageof 8